Martine Tabala
University of Kinshasa
29 Papers
108 Citations
Martine Tabala is an academic researcher from University of Kinshasa. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 11, co-authored 20 publications.
Chat about Author
Papers
Sputum Smear Microscopy: Evaluation of Impact of Training, Microscope Distribution, and Use of External Quality Assessment Guidelines for Resource-Poor Settings
A. Van Rie,Daniel W. Fitzgerald,G. Kabuya,A. Van Deun,Martine Tabala,N. Jarret,F. Behets,E. Bahati +7 more
TL;DR: The evaluated the effects of a 5-day refresher training course for laboratory technicians and the distribution of new microscopes on the quality of smear microscopy in 13 primary health care laboratories in Kinshasa, Democratic Republic of Congo, and concluded that the 2002 external QA guidelines are feasible for implementation in resource-poor settings.
60
Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.
Kathrin Zürcher,Kathrin Zürcher,Kathrin Zürcher,Marie Ballif,Lukas Fenner,Sonia Borrell,Sonia Borrell,Peter M Keller,Joachim Gnokoro,Olivier Marcy,Marcel Yotebieng,Lameck Diero,E. Jane Carter,Neesha Rockwood,Neesha Rockwood,Robert J. Wilkinson,Robert J. Wilkinson,Robert J. Wilkinson,Helen Cox,Nicholas Ezati,Alash'le Abimiku,Jimena Collantes,Anchalee Avihingsanon,Kamon Kawkitinarong,Miriam Reinhard,Miriam Reinhard,Rico Hömke,Robin Huebner,Sebastien Gagneux,Sebastien Gagneux,Erik C. Böttger,Matthias Egger,Matthias Egger,Frédérique Chammartin,Erik C. Boettger,Peter M. Keller,Alash’le Abimiku,Landry Kipula Wenzi,Martine Tabala,Robin M. Warren,Elizabeth M. Streicher,Carlos Zamudio,Annette H. Sohn,Tor Petersen,Naruporn Kasipong,Kouassi N'Guessan +45 more
TL;DR: Rapid molecular drug susceptibility test of first-line and second-line drugs at diagnosis is required to improve outcomes in patients with MDR tuberculosis and pre-XDR or XDR tuberculosis.
Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study
Peyton Thompson,Camille E. Morgan,Patrick Ngimbi,Kashamuka Mwandagalirwa,Noro Ravelomanana,Martine Tabala,Malongo Fathy,Bienvenu Kawende,Jérémie Muwonga,Pacifique Misingi,Charles Mbendi,Christophe Luhata,Ravi Jhaveri,Gavin Cloherty,Didine Kaba,Marcel Yotebieng,Jonathan B. Parr +16 more
TL;DR: In this article, the feasibility and acceptability of adding HBV testing and treatment of pregnant women as well as the birth-dose vaccination of HBV-exposed infants to the HIV prevention of mother-to-child transmission infrastructure in the Democratic Republic of the Congo was evaluated.
43
HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI‐PMTCT study
Marcel Yotebieng,Christian Mpody,Noro Lr Ravelomanana,Martine Tabala,Fathy Malongo,Bienvenu Kawende,Paul Ntangu,Frieda Behets,Emile Okitolonda,Cqi-Pmtct study team +9 more
TL;DR: In this paper, the authors report estimates of undetectable and suppressed viral load among pregnant or breastfeeding women in HIV care in Kinshasa, Democratic Republic of Congo (DRC) and associated risk factors.
37
Mortality among tuberculosis patients in the Democratic Republic of Congo.
TL;DR: High mortality in the first months of anti-tuberculosis treatment could be reduced by addressing diagnostic delays, particularly for extra-pulmonary and smear-negative TB cases and, in HIV-infected patients, by initiation of ART soon after starting anti-Tuber tuberculosis treatment.
31